S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
“The Bull Market Is Officially OVER”  (Ad)
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
“The Bull Market Is Officially OVER”  (Ad)
Can I Apply for Supplemental Security Income Online?
US stocks edge lower in unsteady trading, oil prices rise
Reclusive trader scores 20 straight years of winning trades. Learn how (Ad)
Why Investors Are Eating Up Restaurant Brands International
Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
“The Bull Market Is Officially OVER”  (Ad)
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
“The Bull Market Is Officially OVER”  (Ad)
Can I Apply for Supplemental Security Income Online?
US stocks edge lower in unsteady trading, oil prices rise
Reclusive trader scores 20 straight years of winning trades. Learn how (Ad)
Why Investors Are Eating Up Restaurant Brands International
Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
“The Bull Market Is Officially OVER”  (Ad)
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
“The Bull Market Is Officially OVER”  (Ad)
Can I Apply for Supplemental Security Income Online?
US stocks edge lower in unsteady trading, oil prices rise
Reclusive trader scores 20 straight years of winning trades. Learn how (Ad)
Why Investors Are Eating Up Restaurant Brands International
Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
“The Bull Market Is Officially OVER”  (Ad)
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
“The Bull Market Is Officially OVER”  (Ad)
Can I Apply for Supplemental Security Income Online?
US stocks edge lower in unsteady trading, oil prices rise
Reclusive trader scores 20 straight years of winning trades. Learn how (Ad)
Why Investors Are Eating Up Restaurant Brands International
Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
NASDAQ:MASI

Masimo - MASI Stock Forecast, Price & News

$140.65
-1.31 (-0.92%)
(As of 11/29/2022 12:00 AM ET)
Add
Compare
Today's Range
$140.19
$144.10
50-Day Range
$110.88
$148.16
52-Week Range
$108.89
$299.78
Volume
270,757 shs
Average Volume
683,059 shs
Market Capitalization
$7.39 billion
P/E Ratio
46.57
Dividend Yield
N/A
Price Target
$190.29

Masimo MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.86 Rating Score
Upside/​Downside
35.3% Upside
$190.29 Price Target
Short Interest
Healthy
5.38% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.86
Upright™ Environmental Score
News Sentiment
0.32mentions of Masimo in the last 14 days
Based on 3 Articles This Week
Insider Trading
Acquiring Shares
$4.97 M Bought Last Quarter
Proj. Earnings Growth
-1.80%
From $4.45 to $4.37 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.92 out of 5 stars

Medical Sector

37th out of 1,038 stocks

Electromedical Equipment Industry

2nd out of 23 stocks

MASI stock logo

About Masimo (NASDAQ:MASI) Stock

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.

Receive MASI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Masimo and its competitors with MarketBeat's FREE daily newsletter.

MASI Stock News Headlines

H2O: the FT investigation’s big finale
The Wall Street fight that has echoes of the cold war
The One Stock To Watch In This Market.
This Little Known Company Is Growing While The Economy is Slowing.pixel
Millionaire Investor Reveals: “How I Made My Second Fortune… By Avoiding 99% of Stocks”
Buy this small group of unique stocks… never sell them… and make all the money you need… No matter what happens in the market. Revealed here: the name and ticker of the #1 stock. pixel
Masimo Third Quarter 2022 Earnings: Beats Expectations
Masimo to Present in Stifel 2022 Healthcare Conference
Masimo Reports Third Quarter 2022 Financial Results
Masimo (MASI) Q3 Earnings and Revenues Surpass Estimates
Why Masimo (MASI) Might Surprise This Earnings Season
Masimo Sets the Record Straight on Bylaw Amendments
Should You Invest in Masimo Corp. (MASI)?
See More Headlines
Receive MASI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Masimo and its competitors with MarketBeat's FREE daily newsletter.

MASI Company Calendar

Last Earnings
10/25/2021
Today
11/30/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/21/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:MASI
CUSIP
57479510
Employees
6,200
Year Founded
1989

Price Target and Rating

Average Stock Price Forecast
$190.29
High Stock Price Forecast
$295.00
Low Stock Price Forecast
$135.00
Forecasted Upside/Downside
+35.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
7 Analysts

Profitability

Net Income
$229.65 million
Pretax Margin
12.28%

Debt

Sales & Book Value

Annual Sales
$1.24 billion
Cash Flow
$4.76 per share
Book Value
$23.83 per share

Miscellaneous

Free Float
47,466,000
Market Cap
$7.39 billion
Optionable
Optionable
Beta
0.87

Social Links


Key Executives

  • Mr. Joseph E. KianiMr. Joseph E. Kiani (Age 57)
    Founder, CEO & Chairman
    Comp: $4.22M
  • Mr. Micah YoungMr. Micah Young (Age 43)
    Exec. VP of Fin. & CFO
    Comp: $773.81k
  • Mr. Bilal MuhsinMr. Bilal Muhsin (Age 41)
    Chief Operating Officer
    Comp: $986.31k
  • Mr. Thomas Samuel McClenahan (Age 49)
    Exec. VP, Gen. Counsel & Corp. Sec.
    Comp: $774.53k
  • Mr. Tao Leopold Levy (Age 48)
    Exec. VP of Bus. Devel.
    Comp: $631.6k
  • Mr. Yongsam Lee (Age 57)
    Exec. VP & Chief Information Officer
  • Dr. Steven J. Barker (Age 77)
    Chairman of Scientific Advisory Board & Chief Science Officer
  • Mr. Eli Kammerman
    VP of Bus. Devel. & Investor Relations
  • Mr. Jon ColemanMr. Jon Coleman (Age 58)
    Pres of Worldwide Sales, Professional Services & Medical Affairs
  • Mr. Anand SampathMr. Anand Sampath (Age 56)
    Exec. VP of Operations & Clinical Research













MASI Stock - Frequently Asked Questions

Should I buy or sell Masimo stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last year. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MASI shares.
View MASI analyst ratings
or view top-rated stocks.

What is Masimo's stock price forecast for 2023?

7 brokerages have issued 12-month price objectives for Masimo's stock. Their MASI share price forecasts range from $135.00 to $295.00. On average, they anticipate the company's stock price to reach $190.29 in the next year. This suggests a possible upside of 35.3% from the stock's current price.
View analysts price targets for MASI
or view top-rated stocks among Wall Street analysts.

How have MASI shares performed in 2022?

Masimo's stock was trading at $292.78 at the beginning of the year. Since then, MASI shares have decreased by 52.0% and is now trading at $140.65.
View the best growth stocks for 2022 here
.

When is Masimo's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 21st 2023.
View our MASI earnings forecast
.

How were Masimo's earnings last quarter?

Masimo Co. (NASDAQ:MASI) issued its quarterly earnings data on Monday, October, 25th. The medical equipment provider reported $0.94 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.03. The medical equipment provider had revenue of $307.40 million for the quarter, compared to analysts' expectations of $295.79 million. Masimo had a trailing twelve-month return on equity of 18.04% and a net margin of 9.78%. The business's revenue for the quarter was up 10.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.80 earnings per share.

What guidance has Masimo issued on next quarter's earnings?

Masimo issued an update on its fourth quarter earnings guidance on Tuesday, November, 8th. The company provided earnings per share (EPS) guidance of $1.11-1.22 for the period, compared to the consensus earnings per share estimate of $1.25. The company issued revenue guidance of $581-611 million, compared to the consensus revenue estimate of $617.17 million.

What is Joe E. Kiani's approval rating as Masimo's CEO?

136 employees have rated Masimo Chief Executive Officer Joe E. Kiani on Glassdoor.com. Joe E. Kiani has an approval rating of 90% among the company's employees.

What other stocks do shareholders of Masimo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Netflix (NFLX), Shopify (SHOP), Okta (OKTA), PayPal (PYPL), Alibaba Group (BABA), Mastercard (MA), Trade Desk (TTD), Walt Disney (DIS) and Twilio (TWLO).

What is Masimo's stock symbol?

Masimo trades on the NASDAQ under the ticker symbol "MASI."

Who are Masimo's major shareholders?

Masimo's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (10.30%), Politan Capital Management LP (8.84%), Vanguard Group Inc. (8.80%), State Street Corp (3.15%), RTW Investments LP (2.74%) and Liontrust Investment Partners LLP (2.17%). Insiders that own company stock include Adam Mikkelson, Anand Sampath, Bilal Muhsin, Craig B Reynolds, H Michael Cohen, Joe E Kiani, Jon Coleman, Micah W Young, Ramshorst David J Van, Sanford Fitch, Steven Barker, Tao Levy, Thomas Samuel Mcclenahan and Yongsam Lee.
View institutional ownership trends
.

How do I buy shares of Masimo?

Shares of MASI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Masimo's stock price today?

One share of MASI stock can currently be purchased for approximately $140.65.

How much money does Masimo make?

Masimo (NASDAQ:MASI) has a market capitalization of $7.39 billion and generates $1.24 billion in revenue each year. The medical equipment provider earns $229.65 million in net income (profit) each year or $3.02 on an earnings per share basis.

How many employees does Masimo have?

The company employs 6,200 workers across the globe.

How can I contact Masimo?

Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The official website for the company is www.masimo.com. The medical equipment provider can be reached via phone at (949) 297-7000, via email at ekammerman@masimo.com, or via fax at 949-297-7001.

This page (NASDAQ:MASI) was last updated on 11/30/2022 by MarketBeat.com Staff